Brandywine Managers’s Fulcrum Therapeutics FULC Stock Holding History

Brandywine Managers’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-26,127	Closed	-$162K	–	37
2024 Q2	$162K	Hold	26,127	–	–	0.17%	35
2024 Q1	$247K	Hold	26,127	–	–	0.24%	37
2023 Q4	$176K	Hold	26,127	–	–	0.19%	41
2023 Q3	$116K	Hold	26,127	–	–	0.2%	37
2023 Q2	$86.2K	Hold	26,127	–	–	0.06%	47
2023 Q1	$74.5K	Hold	26,127	–	–	0.05%	47
2022 Q4	$190K	Hold	26,127	–	–	0.66%	36
2022 Q3	$211K	Hold	26,127	–	–	0.69%	35
2022 Q2	$128K	Hold	26,127	–	–	0.31%	41
2022 Q1	$618K	Buy	26,127 +847	+3%	+$12K	1.07%	26
2021 Q4	$447K	Buy	25,280 +4,892	+24%	+$96.9K	0.51%	36
2021 Q3	$575K	Hold	20,388	–	–	0.6%	34
2021 Q2	$214K	Hold	20,388	–	–	0.24%	44
2021 Q1	$240K	Hold	20,388	–	–	0.32%	43
2020 Q4	$239K	Hold	20,388	–	–	0.33%	40
2020 Q3	$162K	Buy	20,388 +5,000	+32%	+$60.2K	0.31%	39
2020 Q2	$281K	Hold	15,388	–	–	1.15%	32
2020 Q1	$184K	Buy	15,388 +4,000	+35%	+$64K	0.06%	35
2019 Q4	$189K	Sell	11,388 -18,312	-62%	-$175K	0.06%	48
2019 Q3	$197K	Buy	+29,700	New	+$329K	0.07%	47

Other funds holding FULC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Brandywine Managers's FULC Position: Q3 2024 in Review

Brandywine Managers sold out of Fulcrum Therapeutics (FULC) in Q3 2024, closing a stake of 26,127 shares — an estimated $162K sold.

Brandywine Managers first reported a position in FULC in Q3 2019 and held it in 20 quarters. The position peaked at $618K in Q1 2022. 130 funds tracked by Wall St. Rank hold FULC as of Q3 2024.

Brandywine Managers reported no remaining Fulcrum Therapeutics position as of Q3 2024 after selling out during the quarter.
Brandywine Managers sold 26,127 Fulcrum Therapeutics shares in Q3 2024, an estimated $162K.
Brandywine Managers first reported a position in Fulcrum Therapeutics in Q3 2019 and held it in 20 quarters.
Brandywine Managers's Fulcrum Therapeutics position peaked at $618K in Q1 2022.
130 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2024.

Based on Brandywine Managers's 13F filing for Q3 2024, filed 14 Nov 2024.